Page last updated: 2024-09-05

s 16020-2 and Astrocytoma, Grade IV

s 16020-2 has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aubert, G; Grill, J; Kalifa, C; Lucas, C; Merlin, JL; Morizet, J; Parker, F; Poullain, MG; Sainte-Rose, C; Sévenet, N; Terrier-Lacombe, MJ; Vassal, G	1

Other Studies

1 other study(ies) available for s 16020-2 and Astrocytoma, Grade IV

Article	Year
In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts. Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:5 Topics: Animals; Carbazoles; Cerebellar Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Gene Expression Regulation; Glioblastoma; Medulloblastoma; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase II Inhibitors; Transplantation, Heterologous	2003

Article

Year

In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts.

Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:5

Topics: Animals; Carbazoles; Cerebellar Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Gene Expression Regulation; Glioblastoma; Medulloblastoma; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase II Inhibitors; Transplantation, Heterologous

2003